forecasted federal funding opportunity

Studies Addressing Rare Neurodegenerative Diseases including ALS

The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development of interventions intended to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and children. Through the support of these studies, FDA expects to…

Agency

Food and Drug Administration

Opportunity number

FOR-FD-25-006